Evidence map›Paper›PMID 41458657›Full record

ArticleCureus2025

New-Onset Systemic Lupus Erythematosus Complicated by Preeclampsia, HELLP Syndrome, and Lupus Nephritis During a Third-Trimester Pregnancy: A Case Report.

Ava Josephson, Morgan Alexander, Aditi Radhakrishnan, Lisbeth Tolentino-Rodriguez

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ava JosephsonCollege of Pharmacy and Health Sciences, Campbell University, Buies Creek, USA.
Morgan AlexanderSchool of Public Health, University of Washington, Seattle, USA.
Aditi RadhakrishnanDepartment of Research, Uplift North Hills Preparatory, Irving, USA.
Lisbeth Tolentino-RodriguezDepartment of Research, Global Health Leaders, Gilbert, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that primarily affects women of reproductive age. Most patients are diagnosed prior to conception; however, new-onset SLE during pregnancy is rare and can mimic common obstetric complications, delaying diagnosis and treatment. Such overlap increases the risk of maternal morbidity and adverse pregnancy outcomes (APOs). A primigravida adolescent in her third trimester presented with severe preeclampsia, HELLP syndrome, and nephrotic-range proteinuria. Postpartum, she developed hemorrhage requiring a modified B-Lynch suture in the ICU, along with vulvar edema, discoid skin lesions, joint pain, and photosensitivity. Laboratory evaluation revealed positive antinuclear antibodies, anti-double-stranded DNA antibodies, hypocomplementemia (characterized by low levels of C3 and C4), and proteinuria, confirming the diagnosis of new-onset SLE with lupus nephritis. The clinical course was managed with corticosteroids, hydroxychloroquine, and supportive therapy. This case highlights the diagnostic complexity of autoimmune disease in pregnancy, particularly when clinical manifestations overlap with obstetric emergencies such as HELLP syndrome and preeclampsia. It underscores the need for early consideration of SLE in atypical or multisystem presentations, prompt biomarker testing, and timely initiation of immunosuppressive therapy. Management in a specialized center, with a multidisciplinary team, is essential to optimizing maternal and neonatal outcomes.

Indexed as

autoimmune diseasehellp syndromehigh-risk obstetricslupus nephritispreeclampsiapregnancysystemic lupus erythematosus

Identifiers

PMID41458657
PMCPMC12739187

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.